IL17F and B-cell chronic lymphocytic leukemia: IL-17F triggered a modest increase in activation of the canonical pNFkBp105 pathway in CLL donor CD4−CD3+T (CD8) cells and CD4+CD3+ T cells (Fig. 6) but no activation of signaling in healthy donor T cells.